Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Patent
1995-06-07
1999-12-28
Minnifield, Nita
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
4242371, 4241941, 4241931, 42419711, 4242441, 4242401, 424831, 4242361, 4242431, 4242491, 4242501, 4242561, 4242571, 4242581, 4242591, 4242601, 530402, 530403, 530395, 514 2, 514 8, 514 12, A61K 3900, A61K 39102, C07K 100, C07K 1400
Patent
active
060078189
ABSTRACT:
An oligoside derived from an antigen polyoside obtained from a pathogenic agent, a method for its preparation, and its use particularly as a vaccinal agent. The oligoside is prepared by oxidation-reduction depolymerisation reaction.
REFERENCES:
patent: 4356170 (1982-10-01), Jennings et al.
patent: 4663160 (1987-05-01), Tsay
patent: 4673574 (1987-06-01), Anderson
patent: 4711779 (1987-12-01), Porro et al.
patent: 4727136 (1988-02-01), Jennings et al.
patent: 4762713 (1988-08-01), Anderson
patent: 4808700 (1989-02-01), Anderson
patent: 5122450 (1992-06-01), Feizi et al.
patent: 5153312 (1992-10-01), Porro et al.
patent: 5204098 (1993-04-01), Szu et al.
patent: 5302386 (1994-04-01), Kasper et al.
patent: 5306492 (1994-04-01), Porro et al.
patent: 5370872 (1994-12-01), Cryz et al.
patent: 5445817 (1995-08-01), Schneerson et al.
patent: 5476929 (1995-12-01), Briles et al.
Uchida et al, "Oxidative depolymerisation of polymerisation of polysaccharides induced by the ascorbic acid-copper ion systems", Agricultural and Biological Chemistry, vol. 50, No. 10, 1986. pp. 2579-2583.
Paoletti et al, "An oligosaccharide-tetanus toxoid conjugate vaccine against type iii group b streptococcus", Journal of Biological Chemistry, vol. 265, No. 30, 1990, pp. 18278-18283.
Szu et al, "Ultrasonic irradiation of bacterial polysaccharides, characterization of the depolymerized products and some applications of the process", Carbohydrate Research, vol. 152, 1986, pp. 7-20.
Hayes, Science 260:1279-1286 (1993).
Fox,Bio/Technology 12:128 (1994).
Porro et al., Medicine Tropicals, 43(2), 129 (1983).
Porro et al., Molecular Immunology , 22(8), 907 (1985).
Meikle and Bundle, Glycoconjugate J., 7, 207 (1990).
Edelman et al. 1990. Int. Rev. Immunol. 7:51-66.
Schneerson et al. 1992. Inf & Imm. 60(9):3528-3532.
Cryz et al. 1990. Inf & Imm 58(2):373-377.
Langer 1990. Science 249:1528-1533.
Anderson et al. 1985 J. Clin. Invest. 76:52-59.
Munson 1990. Can. J. Vet. Res. 54:563-567.
Lee et al. 1994. Vaccine 12(10): 875-878.
Fattom et al. 1990. Inf & Imm. 58(7):2367-2374.
Aron et al. 1993. J. Clin. Microbiol. 31(4):975-978.
Schneerson et al. 1980 J. Exp. Med. 152:361-376.
Jennings 1992 J. Inf. Dis. 165(Supp4):S156-S159.
Szu et al. 1989 Inf. & Imm. 57(12):3823-3827.
Szu et al 1987 J. Exp. Med. 166:1510-1524.
Sarvas et al. 1988. Scand. J. Immunol. 28:471-79.
Minnifield Nita
Pasteur Merieux Serums et Vaccines
LandOfFree
Oligosaccharide derived from an antigenic polysaccharide obtaine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligosaccharide derived from an antigenic polysaccharide obtaine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligosaccharide derived from an antigenic polysaccharide obtaine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2380494